SecBot SecBot
144 ·Filed Apr 7, 2026

OABIW

OmniAb, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0002001011-26-000043
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, non-discretionary sale to cover tax liabilities, not a signal of insider sentiment. Traders should not interpret this as negative — no additional insider selling should be expected beyond these tax-related transactions unless further filings emerge.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
OABIW ▲ 0.00% at T+60d
NEUTRAL call 0.00% · α vs SPY -10.46% · entry $0.0900 → $0.0900
Entry = T+0 close
Apr 7, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.57%
$0.0900
settled 7mo ago
T+5d
0.00%
call 0.00% · α -3.52%
$0.0900
settled 7mo ago
T+20d
0.00%
call 0.00% · α -8.54%
$0.0900
settled 6mo ago
T+60d
0.00%
call 0.00% · α -10.46%
$0.0900
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Matthew W. Foehr, an officer of OmniAb, filed a Form 144 to notify the SEC of a proposed sale of 36,459 shares of common stock. The sale is not discretionary but is intended to cover tax withholding obligations related to the vesting of restricted stock units, as mandated by company policy.

Key Facts

  • Reporting person: Matthew W. Foehr, Officer of OmniAb
  • Proposed sale: 36,459 shares of common stock
  • Reason for sale: Tax withholding obligation from RSU vesting (sell-to-cover)
  • Date of filing: April 7, 2026
  • Broker: Morgan Stanley Smith Barney LLC
  • Shares are restricted and issued under equity incentive plans

Financial Impact

Approximately $613,000 based on 28,577.34 shares at $21.45/share (implied price from total value $613,000), though exact value depends on market price at execution

shares outstandinginsider ownershippotential short-term supply

Risk Factors

  • Potential short-term downward pressure if the full amount is sold rapidly
  • Perception risk if market misinterprets the sale as discretionary

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0002001011-26-000043
Document: 0002001011-26-000043-index.html0002001011-26-000043
Document: 0002001011-26-000043.txt0002001011-26-000043
5 reports for OABIW
Performance horizon
Filters
Rows
Reports for OABIW — sortable, filterable
TypeNow
Jul 13, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$0.0809 $0.0800▼ −1.11%▼ −4.30%—
Apr 7, 2026
28w ago
144
NEUTRAL ★ 3/10
$0.0900 $0.0900· 0.00%▼ −8.54%—
Apr 7, 2026
28w ago
144
NEUTRAL ★ 3/10
$0.0900 $0.0900· 0.00%▼ −8.54%—
Apr 7, 2026
28w ago
144
NEUTRAL ★ 3/10
$0.0900 $0.0900· 0.00%▼ −8.54%—
Mar 4, 2026
33w ago
8-K
MIXED ★ 6/10
—awaiting T+20——
Showing 5 of 5

US Market Status

Market Closed — Opens Wed (13h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026